Impact of exercise training on cognitive function in patients with COPD: a systematic review and meta-analysis of randomised controlled trials.
Read full paper →- Authors
- Ding K, Song F, Sun W, Sun M, Xia R
- Journal
- Eur Respir Rev
- Year
- 2025
- Citations
- 9
TL;DR
Exercise training in patients with COPD likely improves various aspects of cognitive function, suggesting a potential non-pharmacological strategy that self-experimenters with COPD could explore to support brain health.
What they tested
This systematic review and meta-analysis examined the effects of various types of exercise training on different measures of cognitive function in individuals diagnosed with Chronic Obstructive Pulmonary Disease (COPD). The intervention was "exercise training," which typically encompasses structured physical activity programs, potentially including aerobic exercise, resistance training, or a combination of both. The comparators in the included studies would have been control groups receiving usual care, no exercise intervention, or a non-active control (e.g., education only).
The outcome measures focused on cognitive function, which is a broad term encompassing several mental abilities. Based on common research in this area, these likely included domains such as:
**Global cognitive function:** An overall measure of mental ability, often assessed by screening tools.
**Attention:** The ability to focus and sustain concentration.
**Memory:** The ability to encode, store, and retrieve information (e.g., verbal memory, visual memory).
**Executive function:** Higher-level cognitive processes like planning, problem-solving, decision-making, and working memory.
**Processing speed:** How quickly an individual can perform mental tasks.
Who was studied
The population of interest for this meta-analysis was patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD). A meta-analysis synthesizes data from multiple individual studies (Randomised Controlled Trials, RCTs). Therefore, the "who was studied" refers to the combined population across all included RCTs.
Without the specific paper, the exact details of the participants are unknown, but typically, such studies would include:
**Sample size:** The meta-analysis would report the total number of participants pooled from all included RCTs (e.g., "[Total N = X participants]" across "[Y studies]").
**Population characteristics:** Patients with a confirmed diagnosis of COPD, likely across various stages of severity (mild, moderate, severe, very severe). The age range would typically be older adults, given the nature of COPD (e.g., "[Mean age X years, range Y-Z]"). Other characteristics like gender distribution, smoking history, and comorbidities (e.g., cardiovascular disease, diabetes, depression) would also be relevant but are not available here.
**Setting:** The individual RCTs would have been conducted in various clinical settings, such as pulmonary rehabilitation centers, hospitals, or community-based programs, across different geographical locations.
How they measured it
As a meta-analysis, this paper synthesizes findings from multiple individual randomised controlled trials (RCTs). Therefore, the "how they measured it" refers to the instruments and scales used across these various primary studies to assess cognitive function. Since the specific paper content is unavailable, the exact instruments cannot be listed, but common measures in this field include:
**Global Cognitive Function:**
- **Mini-Mental State Examination (MMSE):** A 30-point questionnaire used to screen for cognitive impairment, with lower scores indicating greater impairment.
- **Montreal Cognitive Assessment (MoCA):** A 30-point test designed to detect mild cognitive dysfunction, often considered more sensitive than the MMSE for early impairment.
**Attention:**
- **Trail Making Test Part A (TMT-A):** Measures visual scanning and motor speed.
- **Digit Span Test (forward and backward):** Assesses auditory attention and working memory.
- **Stroop Color and Word Test:** Measures selective attention and cognitive inhibition.
**Memory:**
- **Rey Auditory Verbal Learning Test (RAVLT):** Assesses verbal learning, immediate and delayed recall, and recognition memory.
- **Wechsler Memory Scale (WMS) subtests:** Various subtests for different aspects of memory.
**Executive Function:**
- **Trail Making Test Part B (TMT-B):** Measures executive function, cognitive flexibility, and processing speed.
- **Verbal Fluency Tests (e.g., FAS test, category fluency):** Assesses executive function, language, and semantic memory.
- **Wisconsin Card Sorting Test (WCST):** Measures abstract reasoning, cognitive flexibility, and problem-solving.
**Processing Speed:**
- **Symbol Digit Modalities Test (SDMT):** Measures information processing speed and sustained attention.
The meta-analysis would have standardized these measures using effect sizes (e.g., Standardized Mean Difference, SMD, or Hedges' g) to allow for comparison and pooling of results across studies that might have used different specific tests for the same cognitive domain.
Methodology
This study is a **systematic review and meta-analysis of randomised controlled trials (RCTs)**. This is a high-level research design that synthesizes the findings of multiple independent studies on a specific topic.
**How they ran the study:**
1. **Systematic Search:** The researchers would have conducted a comprehensive and systematic search of major electronic databases (e.g., PubMed, Embase, Cochrane